Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study

Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study

10.1182/bloodadvances.2022006960

Saved in:
Bibliographic Details
Main Authors: Jang, Jun Ho, Wong, Lily, Ko, Bor-Sheng, Yoon, Sung-Soo, Li, Katie, Baltcheva, Irina, Nidamarthy, Prasanna Kumar, Chawla, Raghav, Junge, Guido, Yap, Eng Soo
Other Authors: MEDICINE
Format: Article
Language:English
Published: ELSEVIER 2023
Subjects:
Science & Technology
Life Sciences & Biomedicine
Hematology
COMPLEMENT INHIBITOR ECULIZUMAB
FACTOR B INHIBITOR
HEMOLYSIS
PHASE-3
Online Access:https://scholarbank.nus.edu.sg/handle/10635/237840
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English

Internet

https://scholarbank.nus.edu.sg/handle/10635/237840

Similar Items